These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 15576672)

  • 1. Toll-like receptor 4 or 2 agonists decrease allergic inflammation.
    Velasco G; Campo M; Manrique OJ; Bellou A; He H; Arestides RS; Schaub B; Perkins DL; Finn PW
    Am J Respir Cell Mol Biol; 2005 Mar; 32(3):218-24. PubMed ID: 15576672
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Toll-like receptor 4 agonists adsorbed to aluminium hydroxide adjuvant attenuate ovalbumin-specific allergic airway disease: role of MyD88 adaptor molecule and interleukin-12/interferon-gamma axis.
    Bortolatto J; Borducchi E; Rodriguez D; Keller AC; Faquim-Mauro E; Bortoluci KR; Mucida D; Gomes E; Christ A; Schnyder-Candrian S; Schnyder B; Ryffel B; Russo M
    Clin Exp Allergy; 2008 Oct; 38(10):1668-79. PubMed ID: 18631348
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Toll-like receptor-2 agonist-allergen coupling efficiently redirects Th2 cell responses and inhibits allergic airway eosinophilia.
    Krishnaswamy JK; Jirmo AC; Baru AM; Ebensen T; Guzmán CA; Sparwasser T; Behrens GM
    Am J Respir Cell Mol Biol; 2012 Dec; 47(6):852-63. PubMed ID: 22962064
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surfactant protein D deficiency influences allergic immune responses.
    Schaub B; Westlake RM; He H; Arestides R; Haley KJ; Campo M; Velasco G; Bellou A; Hawgood S; Poulain FR; Perkins DL; Finn PW
    Clin Exp Allergy; 2004 Dec; 34(12):1819-26. PubMed ID: 15663554
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TLR agonist mediated suppression of allergic responses is associated with increased innate inflammation in the airways.
    Duechs MJ; Hahn C; Benediktus E; Werner-Klein M; Braun A; Hoymann HG; Gantner F; Erb KJ
    Pulm Pharmacol Ther; 2011 Apr; 24(2):203-14. PubMed ID: 21195789
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ICOS-expressing CD4 T cells induced via TLR4 in the nasal mucosa are capable of inhibiting experimental allergic asthma.
    Shalaby KH; Jo T; Nakada E; Allard-Coutu A; Tsuchiya K; Hirota N; Qureshi ST; Maghni K; Rioux CR; Martin JG
    J Immunol; 2012 Sep; 189(6):2793-804. PubMed ID: 22908333
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Allergic sensitization is enhanced in early life through toll-like receptor 7 activation.
    Phipps S; Hansbro N; Lam CE; Foo SY; Matthaei KI; Foster PS
    Clin Exp Allergy; 2009 Dec; 39(12):1920-8. PubMed ID: 19735273
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Toll/IL-1 signaling is critical for house dust mite-specific helper T cell type 2 and type 17 [corrected] responses.
    Phipps S; Lam CE; Kaiko GE; Foo SY; Collison A; Mattes J; Barry J; Davidson S; Oreo K; Smith L; Mansell A; Matthaei KI; Foster PS
    Am J Respir Crit Care Med; 2009 May; 179(10):883-93. PubMed ID: 19246719
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Macrophages exposed continuously to lipopolysaccharide and other agonists that act via toll-like receptors exhibit a sustained and additive activation state.
    Hume DA; Underhill DM; Sweet MJ; Ozinsky AO; Liew FY; Aderem A
    BMC Immunol; 2001; 2():11. PubMed ID: 11686851
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TLR4, but not TLR2, mediates IFN-beta-induced STAT1alpha/beta-dependent gene expression in macrophages.
    Toshchakov V; Jones BW; Perera PY; Thomas K; Cody MJ; Zhang S; Williams BR; Major J; Hamilton TA; Fenton MJ; Vogel SN
    Nat Immunol; 2002 Apr; 3(4):392-8. PubMed ID: 11896392
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Muramyldipeptide and diaminopimelic acid-containing desmuramylpeptides in combination with chemically synthesized Toll-like receptor agonists synergistically induced production of interleukin-8 in a NOD2- and NOD1-dependent manner, respectively, in human monocytic cells in culture.
    Uehara A; Yang S; Fujimoto Y; Fukase K; Kusumoto S; Shibata K; Sugawara S; Takada H
    Cell Microbiol; 2005 Jan; 7(1):53-61. PubMed ID: 15617523
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TLR2 and TLR4 stimulation differentially induce cytokine secretion in human neonatal, adult, and murine mononuclear cells.
    Schaub B; Bellou A; Gibbons FK; Velasco G; Campo M; He H; Liang Y; Gillman MW; Gold D; Weiss ST; Perkins DL; Finn PW
    J Interferon Cytokine Res; 2004 Sep; 24(9):543-52. PubMed ID: 15450130
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective priming to Toll-like receptor 4 (TLR4), not TLR2, ligands by P. acnes involves up-regulation of MD-2 in mice.
    Romics L; Dolganiuc A; Kodys K; Drechsler Y; Oak S; Velayudham A; Mandrekar P; Szabo G
    Hepatology; 2004 Sep; 40(3):555-64. PubMed ID: 15349893
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Toll-like receptor 2 ligands activate human basophils for both IgE-dependent and IgE-independent secretion.
    Bieneman AP; Chichester KL; Chen YH; Schroeder JT
    J Allergy Clin Immunol; 2005 Feb; 115(2):295-301. PubMed ID: 15696084
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression and function of Toll-like receptors in chicken heterophils.
    Kogut MH; Iqbal M; He H; Philbin V; Kaiser P; Smith A
    Dev Comp Immunol; 2005; 29(9):791-807. PubMed ID: 15936435
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TLR2 and TLR4 agonists stimulate unique repertoires of host resistance genes in murine macrophages: interferon-beta-dependent signaling in TLR4-mediated responses.
    Toshchakov V; Jones BW; Lentschat A; Silva A; Perera PY; Thomas K; Cody MJ; Zhang S; Williams BR; Major J; Hamilton TA; Fenton MJ; Vogel SN
    J Endotoxin Res; 2003; 9(3):169-75. PubMed ID: 12831458
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TLR3 but not TLR7/8 ligand induces allergic sensitization to inhaled allergen.
    Reuter S; Dehzad N; Martin H; Böhm L; Becker M; Buhl R; Stassen M; Taube C
    J Immunol; 2012 May; 188(10):5123-31. PubMed ID: 22491246
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Local treatment with BPPcysMPEG reduces allergic airway inflammation in sensitized mice.
    Knothe S; Mutschler V; Rochlitzer S; Winkler C; Ebensen T; Guzman CA; Hohlfeld J; Braun A; Muller M
    Immunobiology; 2011; 216(1-2):110-7. PubMed ID: 20619481
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 4-1 BB stimulation inhibits allergen-specific immunoglobulin E production and airway hyper-reactivity but partially suppresses bronchial eosinophilic inflammation in a mouse asthma model.
    Cho YS; Kwon B; Lee TH; Kim TB; Moon KA; La S; Lee J; Lee SD; Oh YM; Moon HB
    Clin Exp Allergy; 2006 Mar; 36(3):377-85. PubMed ID: 16499650
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Toll-like receptor activation during cutaneous allergen sensitization blocks development of asthma through IFN-gamma-dependent mechanisms.
    Haapakoski R; Karisola P; Fyhrquist N; Savinko T; Lehtimäki S; Wolff H; Lauerma A; Alenius H
    J Invest Dermatol; 2013 Apr; 133(4):964-72. PubMed ID: 23151845
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.